These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2206205)

  • 1. Behaviour of lymphocyte subsets in response to immunotherapy with Propionibacterium avidum KP-40 in cancer patients.
    Beuth J; Ko HL; Peters KM; Bornhofen B; Pulverer G
    Zentralbl Bakteriol; 1990 Aug; 273(3):386-90. PubMed ID: 2206205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study on lymphocyte subpopulations in cancer patients after immunostimulation with propionibacteria and in renal transplant patients after combined immunosuppression.
    Peters KM; Pfeiffer R; Bornhofen B; Ko HL; Beuth J; Grundmann R; Pulverer G
    Arzneimittelforschung; 1990 Oct; 40(10):1162-6. PubMed ID: 2149816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunostimulation by propionibacteria--effects on immune status and antineoplastic treatment.
    Isenberg J; Stoffel B; Wolters U; Beuth J; Stützer H; Ko HL; Pichlmaier H
    Anticancer Res; 1995; 15(5B):2363-8. PubMed ID: 8572653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative immunostimulation with propionibacterium avidum KP-40 in patients with gastric carcinoma: a prospective randomized study.
    Peters KM; Beuth J; Ko HL; Pulverer G; Kluger J; Grundmann R
    Onkologie; 1990 Apr; 13(2):124-7. PubMed ID: 2197583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of propionibacterium avidum KP-40 on the proliferation, maturation, emigration and activity of thymocytes and monocytes.
    Ko HL; Winkler C; Beuth J; Tunggal L; Buss G; Jeljaszewicz J; Klippel KF; Pulverer G
    Zentralbl Bakteriol; 1995 Jan; 282(1):86-91. PubMed ID: 7734834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neopterin as a marker of aspecific immunostimulation with Propionibacterium avidum KP-40 in patients with gastrointestinal tumors. A prospective randomized study].
    Peters KM; Bornhofen B; Grundmann R; Ko HL; Beuth J; Waters W; Pichlmaier H; Pulverer G
    Med Klin (Munich); 1990 Jul; 85(7):421-4. PubMed ID: 2385207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined immunostimulation (Propionibacterium avidum KP 40) and anticoagulation (heparin) prevents metastatic lung and liver colonization in mice.
    Beuth J; Ko HL; Uhlenbruck G; Pulverer G
    J Cancer Res Clin Oncol; 1987; 113(4):359-62. PubMed ID: 3597521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local immunotherapy of stomach and intestinal carcinoma by Propionibacterium granulosum.
    Gil J; Orlowski T; Nowakowski W; Ko HL; Roszkowski K; Roszkowski W; Szmigielski S; Pulverer G; Jeljaszewicz J
    Dis Colon Rectum; 1980; 23(8):536-43. PubMed ID: 6970114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined immunomodulation (Propionibacterium avidum KP-40) and lectin blocking (D-galactose) prevents liver tumor colonization in BALB/c-mice.
    Pulverer G; Ko HL; Tunggal L; Beuth J; Jeljaszewicz J
    Zentralbl Bakteriol; 1994 Nov; 281(4):491-4. PubMed ID: 7727896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Propionibacterium avidum KP-40 on the cellular immune system after intensive sport activity.
    Pottkämper M; Randerath O; Beuth J; Pulverer G
    Zentralbl Bakteriol; 1996 Jul; 284(2-3):367-71. PubMed ID: 8837397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Subsets of peripheral blood lymphocytes and tumor infiltrating lymphocytes in cancer patients received chemotherapy].
    Mitachi Y; Murakawa Y; Okuno M; Kambe M; Kanamaru R; Takahasi H; Wakui A
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):482-8. PubMed ID: 2138871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative immunostimulation by Propionibacterium granulosum KP-45 in colorectal cancer.
    Isenberg J; Ko H; Pulverer G; Grundmann R; Stützer H; Pichlmaier H
    Anticancer Res; 1994; 14(3B):1399-404. PubMed ID: 8067712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation by orally administered protein-bound polysaccharide PSK in patients with gastrointestinal cancer.
    Nio Y; Tsubono M; Tseng CC; Morimoto H; Kawabata K; Masai Y; Shiraishi T; Imai S; Ohgaki K; Tobe T
    Biotherapy; 1992; 4(2):117-28. PubMed ID: 1622733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 2.5-year follow-up of local immunotherapy of advanced stomach and intestinal adenocarcinoma with Propionibacterium granulosum.
    Gil J; Badowski A; Orlowski T; Szmigielski S; Ko HL; Jeljaszewicz J; Pulverer G
    J Cancer Res Clin Oncol; 1983; 105(1):98-102. PubMed ID: 6833344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic lymphocytes in rat tumor in situ: effect of intraperitoneal injections of Propionibacterium avidum.
    Hojo H; Endoh YS; Hashimoto Y
    Jpn J Cancer Res; 1985 Jan; 76(1):53-60. PubMed ID: 3918910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of granulopoiesis in pregnant swine and their offspring by Propionibacterium avidum KP-40.
    Markowska-Daniel I; Pejsak Z; Szmigielski S; Jeljaszewicz J; Pulverer G
    Br Vet J; 1992; 148(2):133-45. PubMed ID: 1576517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preoperative nonspecific immunostimulation with Propionibacterium granulosum KP-45 in patients with colorectal cancer. A prospective randomized study].
    Grundmann R; Weber F; Kluger J; Wienand P; Pulverer G
    Chirurg; 1988 Apr; 59(4):272-8. PubMed ID: 3289850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on a biological response modifying LYSAT from Propionibacterium avidum KP 40.
    Pulverer G; Ko HL; Beuth J; Roszkowski K; Roszkowski W; Jeljaszewicz J
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):237-45. PubMed ID: 3223140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant properties of propionibacterium avidum KP-40 in vaccination against endemic viral and bacterial infections. I. Swine immunized with live attenuated Aujeszky's disease virus vaccine and experimentally infected with virulent viruses.
    Markowska-Daniel I; Pejsak Z; Szmigielski S; Jeljaszewicz J; Pulverer G
    Zentralbl Bakteriol; 1992 Dec; 277(4):529-37. PubMed ID: 1338942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective depression of T-lymphocyte subsets in gastric cancer patients: an implication of immunotherapy.
    Lee WJ; Chang KJ; Lee CS; Chen KM
    J Surg Oncol; 1994 Mar; 55(3):165-9. PubMed ID: 8176926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.